2021年発表論文

2020.12.22

2021年に当教室で発表した和文原著です。

題名（論文名）	著者	掲載雑誌
ここが聞きたい！前立腺癌実地診療　神経内分泌癌の治療について教えてください.	岩本大旭、泉浩二、溝上敦	Prostate Cancer Front Line. 2021 Aug; 10 (1): 11-15
前立腺がんに対する内分泌療法と代謝．	重原一慶、溝上敦．	泌尿器科2021; 13(4): 423-430.
尿路性器感染症．治療・管理・再発防止のトピックス．複雑性膀胱炎．	重原一慶、溝上敦.	Uro-Lo 2021; 26(5) : 28-32.
泌尿器科領域におけるトラブルシューティング．肝不全、怖し恐ろし、侮るなかれ.	八重樫洋、泉浩二、溝上敦、佐藤両.	泌尿器外科2021; 34(9): 1068-1070.
発生過程を観察した腎angiomyolipoma with epithelial cystsの1例．	金谷麻央、中野佑亮、吉田耕太郎、戸島史仁、泉浩二、川口昌平、阪口真希、蒲田敏文．	臨床放射線2021; 66(4): 375-379.
泌尿器科腫瘍におけるソマトスタチン受容体シンチグラフィ(オクトレオスキャン)の有用性．	門本卓	泌尿器科2021; 14(2): 240-246.
HPV自己採取による郵送検査を用いた全国調査の中間報告　第2弾	北村唯一、鈴木基文、重原一慶、福田和子	性の健康　2021; 20(3): 16-22.
亀頭のHPVは10年以上に渡り長期存続している. 当財団研究調査.	北村唯一、鈴木基文、重原一慶.	性の健康2021; 20(2): 23-28.
泌尿器科領域におけるトラブルシューティング．　肝不全、怖し恐ろし、侮るなかれ.	八重樫洋、泉浩二、溝上敦、佐藤両.	泌尿器外科2021; 34(9): 1068-1070.

2021年に当教室で発表した英文論文です。

題名（論文名）	著者	掲載雑誌
Similar Recurrence Rate Between Gleason Score of Six at Positive Margin and Negative Margin After Radical Prostatectomy.	Kano H, Kadono Y, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Ikeda H, Mizokami A.	Anticancer Res. 2021;41(1):509-516.
Androgen receptor signaling-targeted therapy and taxane chemotherapy induce visceral metastasis in castration-resistant prostate cancer.	Iwamoto H, Izumi K, Shimada T, Kano H, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Kadono Y, Mizokami A.	Prostate. 2021; 81(1):72-80.
A novel screening strategy for clinically significant prostate cancer in elderly men over 75 years of age.	Iwamoto H, Izumi K, Kadomoto S, Makino T, Naito R, Yaegashi H, Shigehara K, Kadono Y, Mizokami A	Asian J Androl. 2021; 23(1): 36-40.
Transvaginal polytetrafluoroethylene-mesh surgery for pelvic organ prolapse: 1-year clinical outcomes.	Kawaguchi S, Narimoto K, Hamuro A, Nakagawa T, Urata S, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Nohara T, Shigehara K, Izumi K, Tachibana D, Kadono Y, Mizokami A, Koyama M.	Int. J. Urol. 2021; 28(3):268-272.
Recovery of serum testosterone following neoadjuvant androgen deprivation therapy in Japanese prostate cancer patients treated with low-dose rate brachytherapy.	Kato Y, Shigehara K, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.	Aging male 2021; 23(5):1210-1216.
Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cells.	Makino T, Izumi K, Hiratsuka K, Kano H, Shimada T, Nakano T, Kadomoto S, Naito R, Iwamoto H, Yaegashi H, Shigehara K, Kadono Y, Nakata H, Saito Y, Nakagawa-Goto K, Sakai N, Iwata Y, Wada T, Mizokami A.	Sci Rep. 2021;11(1):675.
A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells.	Naito R, Kano H, Shimada T, Makino T, Kadomoto S, Iwamoto H, Yaegashi H, Izumi K, Kadono Y, Nakata H, Saito Y, Goto M, Nakagawa-Goto K, Mizokami A.	Prostate. 2021; 81(5): 295-306.
Testosterone and bone health in men: A narrative review.	Shigehara K, Izumi K, Kadono Y, Mizokami A.	J Clin Med. 2021; 10(3):530.
Durable response achieved using Pazopanib for germ tumor cells: A case report.	Takezawa Y, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Ikeda H, Mizokami A.	Mol Clin Oncol 2021; 14(3):48.
Effectiveness of Vintage Hormone Therapy as Alternative Androgen Deprivation Therapy for Non-metastatic Castration-resistant Prostate Cancer.	Iwamoto H, Kano H, Shimada T, Naito R, Makino T, Kadamoto S, Yaegashi H, Shigehara K, Izumi K, Kadonoa Y, Mizokami A.	In Vivo. 2021;35(2):1247-1252.
A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.	Izumi K, Shima T, Shigehara K, Sawada K, Naito R, Kato Y, Ofude M, Kano H, Iwamoto H, Yaegashi H, Nakashima K, Iijima M, Kawaguchi S, Nohara T, Kadono Y, Mizokami A.	Sci Rep. 2021; 11(1):4455.
Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer.	Saito Y, Mizokami A, Maeda S, Takahashi K, Izumi K, Goto M, Nakagawa-Goto K.	ACS Omega. 2021; 6(7):4842-4849.
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment	Makino T, Izumi K, Mizokami A.	Biomedicines 2021, 9(4), 414.
Sarcopenia and Visceral Metastasis at Cabazitaxel Initiation Predict Prognosis in Patients With Castration-resistant Prostate Cancer Receiving Cabazitaxel Chemotherapy.	Iwamoto H, Kano H, Shimada T, Naito R, Makino T, Kadomoto S, Yaegashi H, Shigehara K, Izumi K, Kadono Y, Mizokami A.	In Vivo. 2021; 35(3):1703-1709.
Blood Cell Count Biomarkers Predicting Efficacy of Pembrolizumab as Second-line Therapy for Advanced Urothelial Carcinoma.	Kadono Y, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kamijima T, Seto C, Takano A, Yotsuyanagi S, Nakagawa R, Miyagi T, Aoyama S, Asahi H, Fukuda R, Mizokami A.	Anticancer Res. 2021;41(3):1599-1606.
Low free testosterone level as a predictor of cardiovascular events in Japanese men with coronary risk factors.	Kato Y, Shigehara K, Inaba T, Sakamoto J, Iijima M, Kawaguchi S, Izumi K, Kadono Y, Namiki M, Mizokami M.	Aging male 2021; 24(1):8-14.
Prevalence and risk factors of human papillomavirus infection among Japanese female people: a nationwide epidemiological survey by self-sampling.	Kitamura T, Suzuki M, Shigehara K, Fukuda K.	Asian Pac J Cancer Prev. 2021;22(6):1843-1849.
Histiocytic sarcoma following combination chemotherapy for primary mediastinal germ cell tumor: a diagnostic dilemma.	Yaegashi H, Kato Y, Nohara T, Izumi K, Kadono Y, Miyagi T, Nakashima T, Yoshimura K, Sato Y, Harada K, Mizokami A.	Int Cancer Conf J. 2021; 10(2):144-148.
α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer.	Saito Y, Mizokami A, Maeda S, Takahashi K, Izumi K, Goto M, Nakagawa-Goto K.	Molecules. 2021;26(9):2812.
Favorable Response of Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma with Only Small Lesions to not be Considered Measurable by RECIST.	Kadono Y, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kamijima T, Seto C, Takano A, Yotsuyanagi S, Nakagawa R, Miyagi T, Aoyama S, Asahi H, Fukuda R, Mizokami A.	Urol J. 2021; 19(3):202-208.
Risk Factors Affecting Decreased Libido among Middle-aged to Elderly Men; Nocturnal Voiding is an Independent Risk Factor of Decreased Libido.	Shigehara K, Kato Y, Iijima M, Kawaguchi S, Nohara T, Izumi K, Kadono Y, Namiki M, Mizokami A.	Sexual Med 2021; 2021;9(5):100426.
Treatment at an inexperienced center suggests worse prognosis of metastatic germ cell tumors.	Yaegashi H, Izumi K, Kadomoto S, Iwamoto H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, Mizokami A.	Cancer Diagonsis & Prognosis. 2021;1:13-17.
Examination of Necessity for Pelvic Drain Placement After Robot-assisted Radical Prostatectomy.	Iwamoto H, Kadono Y, Nakagawa R, Makino T, Kadomoto S, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Mizokami A.	In Vivo. 2021; 35(5):2895-2899.
Androgen replacement therapy for cancer-related symptoms in male: result of prospective randomized trial (ARTFORM study).	Izumi K, Iwamoto H, Yaegashi H, Nohara T, Shigehara K, Kadono Y, Nanjo S, Yamada T, Ohtsubo K, Yano S, Mizokami A.	J Cachexia Sarcopenia Muscle. 2021; 12(4):831-842.
Human papillomavirus detected in sperm of Japanese infertile males affects reproductive parameters.	Kato Y, Shigehara K, Nakagawa T, Nakata H, Iijima M, Nakashima K, Kawaguchi S, Izumi K, Kadono Y, Mizokami A.	Int J Infect Dis. 2021; 112:294-299.
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment.	Kadomoto S, Izumi K, Mizokami A.	Int J Mol Sci. 2021; 22(16):8530.
Treatment Strategies for High-Risk Localized and Locally Advanced and Oligometastatic Prostate Cancer.	Makino T, Izumi K, Iwamoto H, Mizokami A.	Cancers (Basel). 2021; 13(17):4470.
Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment.	Makino T, Izumi K, Mizokami A.	Biomedicines. 2021; 9(4):414.
Three-dimensional morphological analysis of spermatogenesis in aged mouse testes.	Nakano T, Nakata H, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.	Sci Rep. 2021; 11(1):23007.
Histiocytic sarcoma following combination chemotherapy for primary mediastinal germ cell tumor: a diagnostic dilemma.	Yaegashi H, Kato Y, Nohara T, Izumi K, Kadono Y, Miyagi T, Nakashima T, Yoshimura K, Sato Y, Harada K, Mizokami A.	Int Cancer Conf J. 2021; 10(2):144-148.
The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.	Makino T, Sakurai T, Takamatsu S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A.	Int J Clin Oncol; 26(12):2310-2317.
Macrophage Polarity and Disease Control.	Kadomoto S, Izumi K, Mizokami A.	Int J Mol Sci. 2021; 23(1):144.
Variations in photodynamic diagnosis for bladder cancer due to the quality of endoscopic equipment.	Nohara T, Kamijima T, Fukuda R, Kano H, Shimada T, Nakano T, Kato Y, Kadomoto S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, Mizokami A.	Photodiagnosis Photodyn Ther. 2021; 37:102628.

一覧に戻る